血性恶性瘤患者的跌倒风险因素和缓解策略:使用理性模型进行定性研究的见解
Cuishan Chen1,2, Huijuan Song3, Huijuan Xu4
1Department of Nursing, Nanfang Hosptial of Southern Medical University, Guangzhou, 510515, People's Republic of China.
概括
这项研究确定了导致血性恶性瘤患者跌倒风险的关键因素. 调查结果强调需要改善护理实践和组织支持,以提高患者安全并减少跌倒.
科学领域:
- 瘤科 护理 护理专业
- 患者安全 患者安全
- 医疗保健管理的管理
背景情况:
- 血液性恶性瘤对患者护理构成独特的挑战.
- 入院患者,特别是那些患有复杂疾病的患者,跌倒风险是一个重大问题.
- 现有的防摔策略可能无法完全满足血液性恶性瘤患者的特定需求.
研究的目的:
- 调查影响患有血液性恶性瘤的患者跌倒风险的人类和组织因素.
- 应用 Reason 模型来理解这个人群中跌倒的多因素性质.
- 为制定有针对性的摔倒管理策略提供信息.
主要方法:
- 与13名患有血液性恶性瘤的患者和12名瘤护士进行了半结构面试.
- 有目的的抽样确保了相关的参与者选择.
- 专题分析被用来系统地分析定性访谈数据.
主要成果:
- 确定了影响跌倒风险的四个关键主题:不安全实践的先决条件,不安全的监督,不安全的行为和组织的影响.
- 预先条件包括初级护士缺乏经验,患者遵守不良,药物不良反应和设施不足.
- 不安全行为和监督问题与评估变化和患者教育和支持不足有关.
结论:
- 在血液性恶性瘤患者中,使用Reason模型框架阐明了特定的跌倒风险因素.
- 调查结果为开发专门的跌倒风险评估工具提供了理论基础.
- 这项研究旨在提高住院患者的摔倒管理质量,并减少摔倒发生率.
相关概念视频
Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
Cancer Survival Analysis
327
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
327
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Methods of Documentation VI: Case Management Model
559
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
559
Factors Affecting Illness
4.2K
When a person's physical, emotional, intellectual, social development or spiritual functioning is compromised, this deviation from a healthy normal state is called illness. Illness creates stress that in turn harms individuals. Irritation, anger, denial, hopelessness, and fear are behavioral and emotional changes an individual experiences in the phases of illness. A variety of factors influence a person's health and well-being.
For instance, risk factors are connected to illness,...
For instance, risk factors are connected to illness,...
4.2K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


